FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease

Mobilizing colleagues in the then-new Innovative Genome Institute (IGI) — a joint research collaboration between the University of California, Berkeley …

  • You already voted!
  • Read More

Get Unlimited Free Access

Join 6,000 other readers who get their news from us